nodes	percent_of_prediction	percent_of_DWPC	metapath
Brompheniramine—KCNH2—purkinje fiber—dilated cardiomyopathy	0.299	0.464	CbGeAlD
Brompheniramine—KCNH2—endocardium—dilated cardiomyopathy	0.154	0.239	CbGeAlD
Brompheniramine—CYP2C9—cardial valve—dilated cardiomyopathy	0.125	0.194	CbGeAlD
Brompheniramine—Mepyramine—SLC22A5—dilated cardiomyopathy	0.0145	0.509	CrCbGaD
Brompheniramine—KCNH2—cardiac ventricle—dilated cardiomyopathy	0.0129	0.0201	CbGeAlD
Brompheniramine—KCNH2—myocardium—dilated cardiomyopathy	0.0122	0.0189	CbGeAlD
Brompheniramine—CHRM2—heart—dilated cardiomyopathy	0.0118	0.0183	CbGeAlD
Brompheniramine—Orphenadrine—SCN5A—dilated cardiomyopathy	0.00872	0.305	CrCbGaD
Brompheniramine—KCNH2—heart—dilated cardiomyopathy	0.0085	0.0132	CbGeAlD
Brompheniramine—KCNH2—cardiac atrium—dilated cardiomyopathy	0.00727	0.0113	CbGeAlD
Brompheniramine—CYP2B6—heart—dilated cardiomyopathy	0.00698	0.0108	CbGeAlD
Brompheniramine—CYP2C9—heart—dilated cardiomyopathy	0.00691	0.0107	CbGeAlD
Brompheniramine—Diphenhydramine—SLC22A5—dilated cardiomyopathy	0.00531	0.186	CrCbGaD
Brompheniramine—CYP2E1—Metabolism—TAZ—dilated cardiomyopathy	0.000351	0.00107	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00035	0.00107	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00035	0.00107	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000349	0.00107	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000347	0.00106	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000343	0.00105	CbGpPWpGaD
Brompheniramine—HRH1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000336	0.00103	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000335	0.00102	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000335	0.00102	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000335	0.00102	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000334	0.00102	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000332	0.00101	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000331	0.00101	CbGpPWpGaD
Brompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000328	0.001	CbGpPWpGaD
Brompheniramine—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000326	0.000997	CbGpPWpGaD
Brompheniramine—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000325	0.000994	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000325	0.000993	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—SDHA—dilated cardiomyopathy	0.000324	0.000991	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	0.000323	0.000987	CbGpPWpGaD
Brompheniramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000322	0.000984	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—SDHA—dilated cardiomyopathy	0.000318	0.000971	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000315	0.000962	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000311	0.000951	CbGpPWpGaD
Brompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000307	0.000938	CbGpPWpGaD
Brompheniramine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000306	0.000935	CbGpPWpGaD
Brompheniramine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000305	0.000932	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	0.000304	0.000928	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000301	0.000921	CbGpPWpGaD
Brompheniramine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000298	0.00091	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000296	0.000904	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	0.000288	0.000881	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000284	0.000866	CbGpPWpGaD
Brompheniramine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000281	0.000859	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000281	0.000858	CbGpPWpGaD
Brompheniramine—CHRM3—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.00028	0.000857	CbGpPWpGaD
Brompheniramine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000278	0.000848	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	0.000275	0.000839	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	0.000271	0.000828	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000269	0.000822	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000269	0.000821	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	0.000265	0.00081	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	0.000263	0.000803	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00026	0.000796	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00026	0.000796	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00026	0.000793	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00026	0.000793	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000259	0.000791	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000259	0.000791	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000257	0.000787	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000256	0.000783	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000256	0.000783	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000255	0.000779	CbGpPWpGaD
Brompheniramine—CHRM2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000255	0.000779	CbGpPWpGaD
Brompheniramine—HRH1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000249	0.000762	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	0.000249	0.000762	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000249	0.000759	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000248	0.000757	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	0.000247	0.000755	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000245	0.00075	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	0.000245	0.000749	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000244	0.000746	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000242	0.00074	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000241	0.000737	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000241	0.000735	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000238	0.000728	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000237	0.000723	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000237	0.000723	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000236	0.00072	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000236	0.00072	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000235	0.000718	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000235	0.000718	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000235	0.000716	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000234	0.000714	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000233	0.000712	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000233	0.000711	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000233	0.000711	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000233	0.000711	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000231	0.000705	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	0.000226	0.000689	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	0.000224	0.000683	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000223	0.000681	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00022	0.000672	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000219	0.00067	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000218	0.000667	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000218	0.000666	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000216	0.000661	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000213	0.000651	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000212	0.000648	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000212	0.000646	CbGpPWpGaD
Brompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.00021	0.000643	CbGpPWpGaD
Brompheniramine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.00021	0.000641	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00021	0.00064	CbGpPWpGaD
Brompheniramine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000209	0.000639	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000209	0.000638	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000208	0.000636	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000207	0.000631	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000207	0.000631	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.0002	0.000612	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.0002	0.00061	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.0002	0.000609	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000199	0.000608	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000198	0.000605	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000198	0.000604	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000198	0.000604	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000197	0.000602	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000192	0.000587	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00019	0.00058	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00019	0.000579	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000189	0.000579	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000189	0.000578	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000189	0.000577	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000187	0.000571	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000186	0.000568	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000184	0.000562	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000182	0.000556	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000181	0.000554	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000181	0.000553	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000181	0.000552	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000179	0.000547	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000178	0.000544	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	0.000173	0.00053	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000173	0.000527	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000172	0.000525	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000171	0.000524	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00017	0.000519	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000168	0.000512	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000163	0.000498	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	0.000163	0.000498	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000159	0.000485	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000157	0.000481	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000157	0.000479	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000156	0.000478	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000155	0.000473	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000152	0.000465	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000151	0.00046	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.00015	0.000457	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000148	0.000451	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	0.000147	0.00045	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000147	0.000449	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000147	0.000449	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000147	0.000448	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000146	0.000445	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000145	0.000443	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000144	0.000441	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000141	0.000431	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00014	0.000429	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00014	0.000428	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00014	0.000427	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00014	0.000427	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000139	0.000425	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000139	0.000425	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000139	0.000424	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000139	0.000424	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000139	0.000424	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000137	0.00042	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000137	0.00042	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000136	0.000417	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000134	0.000409	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000134	0.000408	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000133	0.000407	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000133	0.000406	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000132	0.000403	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000131	0.000401	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000131	0.000401	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00013	0.000397	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000129	0.000396	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000129	0.000396	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000129	0.000394	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000128	0.000391	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000128	0.00039	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000128	0.00039	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000127	0.000388	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000126	0.000385	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000126	0.000384	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000126	0.000384	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000125	0.000383	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000125	0.000382	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000124	0.000379	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000124	0.000378	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.00012	0.000365	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000117	0.000357	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000112	0.000342	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—AGT—dilated cardiomyopathy	0.000112	0.000341	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000107	0.000328	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000107	0.000327	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—AGT—dilated cardiomyopathy	0.000107	0.000327	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000107	0.000326	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000106	0.000323	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—GPX1—dilated cardiomyopathy	0.000102	0.000313	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000102	0.000311	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000102	0.00031	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000101	0.000309	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.0001	0.000306	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—CD36—dilated cardiomyopathy	9.98e-05	0.000305	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—EGFR—dilated cardiomyopathy	9e-05	0.000275	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—AGT—dilated cardiomyopathy	8.98e-05	0.000274	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.88e-05	0.000271	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.85e-05	0.00027	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.83e-05	0.00027	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—GPX1—dilated cardiomyopathy	8.81e-05	0.000269	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.76e-05	0.000268	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.74e-05	0.000267	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.73e-05	0.000267	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.7e-05	0.000266	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—GPX1—dilated cardiomyopathy	8.63e-05	0.000264	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.62e-05	0.000263	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.62e-05	0.000263	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—CD36—dilated cardiomyopathy	8.58e-05	0.000262	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—CD36—dilated cardiomyopathy	8.41e-05	0.000257	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—RAC1—dilated cardiomyopathy	7.91e-05	0.000242	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	7.89e-05	0.000241	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—RAC1—dilated cardiomyopathy	7.86e-05	0.00024	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	7.79e-05	0.000238	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—RAF1—dilated cardiomyopathy	7.76e-05	0.000237	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—AGT—dilated cardiomyopathy	7.73e-05	0.000236	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—AGT—dilated cardiomyopathy	7.57e-05	0.000231	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—AGT—dilated cardiomyopathy	7.56e-05	0.000231	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—AGT—dilated cardiomyopathy	7.54e-05	0.00023	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—AGT—dilated cardiomyopathy	7.51e-05	0.000229	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	7.46e-05	0.000228	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	7.44e-05	0.000227	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—RAF1—dilated cardiomyopathy	7.43e-05	0.000227	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	7.27e-05	0.000222	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	6.66e-05	0.000203	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	6.54e-05	0.0002	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	6.49e-05	0.000198	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	6.13e-05	0.000187	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.09e-05	0.000186	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	6.07e-05	0.000186	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.07e-05	0.000185	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.05e-05	0.000185	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.99e-05	0.000183	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	5.97e-05	0.000182	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	5.91e-05	0.000181	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	5.84e-05	0.000178	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	5.37e-05	0.000164	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	5.33e-05	0.000163	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—EGFR—dilated cardiomyopathy	5.32e-05	0.000162	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—RAF1—dilated cardiomyopathy	5.25e-05	0.00016	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	5.23e-05	0.00016	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—RAF1—dilated cardiomyopathy	5.21e-05	0.000159	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	5.16e-05	0.000158	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—EGFR—dilated cardiomyopathy	5.09e-05	0.000156	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	4.01e-05	0.000122	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	3.9e-05	0.000119	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—EGFR—dilated cardiomyopathy	3.6e-05	0.00011	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	3.59e-05	0.00011	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—EGFR—dilated cardiomyopathy	3.58e-05	0.000109	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	3.54e-05	0.000108	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	3.51e-05	0.000107	CbGpPWpGaD
